Page 24 - Serum Institute Of India

Findings into 'adverse event' at Serum didn't require halting trial: Govt

The Pune-based vaccine manufacturer on Tuesday said that the vaccine is safe and immunogenic

India Coronavirus Dispatch: How emergency vaccine authorisation works

Queues at Ahmedabad's crematoriums get longer, doubts about AstraZeneca vaccine and bringing diagnostics closer to communities-news relevant to India's fight against Covid-19

Coronavirus vaccine update: Serum vs volunteer fight, PM calls meet, & more

Listen to the podcast to know all the key updates related to vaccine

Covishield's approval process hinges on adverse event investigation

SII has in response stated that the allegations made in the legal notice are 'malicious and misconceived', and that it will seek damages in excess of Rs 100 crore.

Inform people about vaccine in simple language, PM tells manufacturers

Serum Institute in Pune will undertake mass production of Covishield vaccine developed by Oxford-Astra Zeneca

Ambassadors of 100 countries to visit Serum Institute, Gennova Biopharma

Sweden seeks to expand ties with India in health and life sciences, Luxembourg-based firm B Systems is partnering with India to produce portable vaccine refrigeration equipment

Who will get Covid vaccine first? Serum CEO on distribution, pricing & Modi

Top headlines: Tata sons to raise stake in AirAsia; Serum seeks damages

From Tata Sons raising stakes in AirAsia to putting off artillery import embargo, here are top headlines this morning

Serum Institute seeks Rs 100 cr in damages from trial subject

Experts feel trust is broken as trial was not halted; Chennai resident had sought Rs 5 cr in compensation

Oxford vaccine: Serum to apply for emergency-use authorisation in 2 weeks

Serum Institute CEO Adar Poonawalla makes the announcement after a meeting with PM Narendra Modi, who was visiting key vaccine sites in India

Serum Institute to apply for emergency use of Covid vaccine in next 2 weeks

The company is the world's largest vaccine manufacturer.

Serum to submit data on two full doses of Covid-19 vaccine within deadline

Sources said the UK partner, AstraZeneca, would also submit the current data set to the regulator as planned, and provide additional test results, if sought

PM Modi's Serum visit shot in arm for India's Covid-19 vaccine image

Known for cranking out low-price vaccines, Serum Institute comes riding on the promise of a billion Covid shots

Covid updates on vaccine, lockdown chances and PM's Serum institute visit

Russia's sovereign wealth fund and Indian pharmaceutical company Hetero have agreed to produce over 100 million doses per year of Russia's Covid vaccine Sputnik V, in India

Covishield shows 60-70% efficacy; Modi to visit Serum Institute on Saturday

SII is unlikely to announce any interim data from the trials here. It will wait to compile and analyse data, before sharing it with the Indian regulator.

PM to visit Serum Institute in Pune on Nov 28 to review vaccine development

Rao had also informed that ambassadors and envoys from 100 countries will visit the Serum Institute of India and the Gennova Biopharmaceuticals Ltd here on December 4

PM Modi to visit Serum Institute of India in Pune on November 28

Serum Institute has partnered with global pharma giant AstraZeneca and the Oxford University

Envoys from 100 nations to visit Pune amid Covid vaccine production

Visit of the ambassadors was to take place on November 27, but it has now been rescheduled to December 4

Serum Institute to focus on supplying Oxford Covid vaccine to India first

Poonawalla said the company will be able to produce 400 million doses of AstraZeneca's vaccine by July 2021 and scale up further from there

Bill Gates, coronavirus and the initiative to vaccinate the world

If the initiative, aided by Mr. Gates's fortune and focus, manages to help protect the world's poor from a virus it will affirm the strategies he has promoted in his philanthropic work